Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
试验速览
- 阶段
- 4 期
- 发起方
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- changes of symptom scores
研究概览
简要总结
To determine the efficacy of a low FODMAP diet in IBS patients and whether gut microbiota community is associated with its efficacy.
详细描述
We seek to determine whether a low FODMAPs diet decreases symptoms in irritable bowel syndrome (IBS)patients and to identify potential microbial factors related to diet efficacy. Pain symptoms, stooling characteristics, breath hydrogen, stool microbiome will be collected and/or documented in IBS patients at baseline and during one week of an low FODMAPs intervention.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •the presence of Rome III criteria for IBS ;
- •Patients scheduled for colonoscopy examination or having negative screening examinations
- •Aged between 18 and 65 years old
排除标准
- •Antibiotic, probiotic or laxative usage within 4 weeks.
- •organic gastrointestinal diseases
- •Severe systematic disease: diabetes mellitus, hepatic, renal or cardiac dysfunction, thyroid disease or tumor etc.
- •pregnancy or lactation.
- •previous major or complicated abdominal surgery.
- •severe endometriosis and dementia
研究组 & 干预措施
IBS patients
eat the low FODMAPs diet for one week
干预措施: low FODMAPs (Dietary Supplement)
healthy controls
eat the low FODMAPs diet for one week
干预措施: low FODMAPs (Dietary Supplement)
结局指标
主要结局
changes of symptom scores
时间窗: 5 months
次要结局
- proportion of responders(3 months)
- quality of life in IBS patients(5 months)
- microbial composition in different response to low FODMAPs(5 months)
研究者
Yanqing Li
Vice president of Qilu Hospital
Shandong University
